HCPLive

Breakthrough Pain

Latest Headlines

Expectation Versus Reality of Pain Makes All the Difference
Expectation Versus Reality of Pain Makes All the Difference
The saying “it’s all in your head” may not be that far off when it comes to pain, according to a new study measuring brain activity.
One Step Closer to Ending Cancer Pain
University of Toronto researchers have found a novel role for a cell membrane-anchored mediator in cancer pain. They suggest that the serine protease TMPRSS2—a gene previously shown to play a key role in some of the most aggressive forms of androgen-fuelled cancers—appears to be the trigger behind the most severe forms of cancer pain.
Q&A With Gary Franklin, MD, MPH, FAAN, of the University of Washington: The Opioid Epidemic: Where Do We Go From Here?
The opioid epidemic began nearly 30 years ago and since that time small steps have been taken to reverse its effects. The question remains whether too much damage has already been done to fix the problems in a timely manner.
Q&A With Gary Franklin, MD, MPH, FAAN, of the University of Washington: The Opioid Epidemic: Where Did it Begin
For many years the dangers of opioid addiction have been well known. Taking the steps needed to reverse its impact has been slower in taking hold across the country.
Safety Concerns with Breakthrough Cancer Pain Treatments
Like many analgesics, transmucosal immediate-release fentanyl products can be associated with adverse events.
TIRF Products for Breakthrough Cancer Pain
Transmucosal immediate-release fentanyl products are available for the management of breakthrough pain in opioid-tolerant patients with cancer.
Long-Term Management of Breakthrough Cancer Pain
Chronic pain can occur as a direct result of cancer and its treatment. In general, severe pain is most prevalent in patients with advanced cancer, with approximately 70% of patients listing pain as a primary concern.

Most Popular

$vacMongoViewPlus$ $vAR$